145629 Association of Syringe Source and Syringe Sharing in New York City

Monday, November 5, 2007: 12:45 PM

Samuel Jenness, MPH , HIV Epidemiology Program, New York City Department of Health and Mental Hygiene, New York, NY
Holly Hagan, PhD , College of Nursing, New York University, New York, NY
Kai-lih Liu, PhD , HIV Epidemiology Program, New York City Department of Health and Mental Hygiene, New York, NY
Travis Wendel, JD , Center for Drug Use & HIV Research, National Development & Research Institutes, New York, NY
Aundrea Woodall , Center for Drug Use & HIV Research, National Development & Research Institutes, New York, NY
Shavvy Raj-Singh, MPH , HIV Epidemiology Program, New York City Department of Health and Mental Hygiene, New York, NY
Christopher Murrill, PhD , HIV Epidemiology Program, New York City Department of Health and Mental Hygiene, New York, NY
Background. HIV incidence is decreasing among injection drug users (IDU) in New York City, where sterile syringes are available from multiple legal sources. Nevertheless, many IDU continue to share syringes. We explored the relationship between syringe source and sharing.

Methods. We conducted a cross-sectional survey of active IDU recruited through respondent-driven sampling as part of CDC's National HIV Behavioral Surveillance. In a structured interview, participants were asked where they obtained syringes and whether they shared syringes in the past year.

Results. 500 eligible IDU completed the study between July – December 2005. Participants obtained syringes from a syringe exchange (71%), pharmacy (51%), medical provider (11%), friend (55%), or drug dealer (29%). 21% shared syringes. In multiple logistic regression controlling for demographic and injection-related factors (e.g., frequency of injection and number of drugs injected) associated with syringe source, IDU who obtained syringes from a syringe exchange were less likely to share syringes (OR=0.6, p<0.05) while IDU who obtained syringes from a friend (OR=2.2, p<0.01), or a dealer (OR=2.0, p=0.01) were twice as likely to share syringes. Obtaining syringes from a medical provider or pharmacy did not significantly influence sharing.

Conclusions. Syringe sharing varied by source of syringes. Obtaining syringes from drug dealers and friends increased the likelihood of sharing. Two sterile syringe sources (pharmacies and medical providers) were not associated with decreased syringe sharing. Only syringe exchange was associated with a significant decrease in syringe sharing. Exchange programs successfully reduce risk through counseling and support services that other sources cannot provide.

Learning Objectives:
1. Describe the predictors of syringe sharing among Injection Drug Users (IDU). 2. Assess the differences in risk reduction benefits of sterile syringe sources. 3. Discuss future strategies to further reduce HIV transmission risk among IDU.

Keywords: HIV/AIDS, Injection Drug Users

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.